CLASS I ONGOING Device recall · Reported 11 Sep 2024 · FDA Enforcement Report

LVP Primary Administration Set, Dual-Inlet, Low-Sorbing recalled

Fresenius Kabi USA is recalling LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty, distributed in Colorado, Idaho, New Jersey, Utah. The recall was initiated on 1 Aug 2024 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesProduct Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538.
Quantity recalled180 cases/4,500 pieces

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2721-2024
FDA event ID
95113
Recalling firm
Fresenius Kabi USA, North Andover, MA
Classification
Class I
Status
Ongoing
Recall initiated
1 Aug 2024
FDA classified
4 Sep 2024
Reported
11 Sep 2024
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Device Malfunction
Device type
Infusion Pumps

Timeline

1 Aug 2024Recall initiated by company
4 Sep 2024Classified by FDA+34 days
11 Sep 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion.

Where it was distributed

US Distribution to states of: CO, ID, NJ, UT.

ColoradoIdahoNew JerseyUtah

Questions about this recall

Why was it recalled?

A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).

Which lots are affected?

Product Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538.

Where was it sold?

US Distribution to states of: CO, ID, NJ, UT.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Kabi USA

All 95

Other Infusion Pumps recalls

All 546